The FDA advisory panel meets to debate Covid vaccines in infants and youngsters

[The stream is slated to start at 8:30 a.m. ET. Please refresh the page if you do not see a player above at that time.]

A key body of the Food and Drug Administration is holding a meeting Thursday to discuss the use of Covid-19 vaccines in children 6 months and older.

The FDA’s Advisory Committee on Vaccines and Related Biological Products will meet on the same day that Moderna said it had asked the U.S. agency to expand emergency use of its Covid-19 vaccine in adolescents ages 12-17. The vaccine was approved for adults in December.

Pfizer and German partner BioNTech received permission to use their vaccine for 12 to 15 year olds last month.

US regulators are expected to approve Moderna’s application for use on teenagers. The approval process could take about a month, just in time for the fall classes. Pfizer and BioNTech, for example, filed for expanded use of their syringe in teenagers on April 9th ​​and were approved by the FDA on May 10th.

Comments are closed.